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OBJECTIVE: The purpose of this study was to evaluate the clinical outcome and costs after the implementation
of robotic surgery in the treatment of endometrial cancer, compared to the traditional laparoscopic approach.
METHODS: In this prospective randomized study from 2015 to 2017, eighty-nine patients with endometrial
carcinoma that was clinically restricted to the uterus were randomized in robotic surgery (44 cases) and
traditional laparoscopic surgery (45 cases). We compared the number of retrieved lymph nodes, total time
of surgery, time of each surgical step, blood loss, length of hospital stay, major and minor complications,
conversion rates and costs.
RESULTS: The ages of the patients ranged from 47 to 69 years. The median body mass index was 31.1 (21.4-54.2)
in the robotic surgery arm and 31.6 (22.9-58.6) in the traditional laparoscopic arm. The median tumor sizes were
4.0 (1.5-10.0) cm and 4.0 (0.0-9.0) cm in the robotic and traditional laparoscopic surgery groups, respectively. The
median total numbers of lymph nodes retrieved were 19 (3-61) and 20 (4-34) in the robotic and traditional
laparoscopic surgery arms, respectively. The median total duration of the whole procedure was 319.5 (170-520)
minutes in the robotic surgery arm and 248 (85-465) minutes in the traditional laparoscopic arm. Eight major
complications were registered in each group. The total cost was 41% higher for robotic surgery than for
traditional laparoscopic surgery.
CONCLUSIONS: Robotic surgery for endometrial cancer presented equivalent perioperative morbidity to that of
traditional laparoscopic surgery. The duration and total cost of robotic surgery were higher than those of
traditional laparoscopic surgery.
KEYWORDS: Endometrial Cancer; Robotic Surgery; Laparoscopic Surgery; Lymph Node Dissection; Surgery.
’ INTRODUCTION
Endometrial cancer is the eighth most common cancer in
Brazilian women, with 6,950 new cases estimated for 2016 at
an incidence of 6.74 cases per 100,000 women. Endometrial
cancer is more frequent in the southeast region of Brazil (9.58
cases/100,000) (1). Surgery is still considered the main
treatment for endometrial cancer. Most surgeries in Brazil
are still performed by gynecologists and obstetricians in
general hospitals, and most of these clinicians perform only
laparotomic surgeries.
Since 2009, at the Gynecological Division of the Instituto do
Câncer do Estado de São Paulo (ICESP), endometrial cancer has
been preferably treated by laparoscopy, and treatment has
followed the recommendations of FIGO, namely, complete
staging surgery comprising removal of the uterus, ovaries,
uterine tubes, and pelvic and paraaortic lymph nodes (2).
Robotic surgery using the da Vincis robot (Intuitive Surgery
Inc., CA, USA) was introduced to our institution in 2015 as
a research project and has since been used for endometrial
cancer staging. We aimed to evaluate the perioperative
advantages, disadvantages and costs of robotic surgery
compared to traditional laparoscopic surgery in patients
with endometrial cancer.
’ METHODS
Patients with endometrial cancer at the ICESP and can-
didates for primary surgical treatment were prospectively
identified through the hospital’s electronic medical record.DOI: 10.6061/clinics/2017/e522s
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From January 2015 to June 2017, ninety consecutive patients
with endometrial cancer that was apparently restricted to the
uterus and candidates for minimally invasive surgeries were
randomized to robotic or traditional laparoscopic surgical
arms. Two experienced laparoscopic surgeons performed both
the robotic and the traditional laparoscopic surgeries (ASS and
JPMC). The study was approved by the center’s Institutional
Review Board, and written informed consent was provided by
all patients (number of protocol CEP-FMUSP 438/13).
The method of randomization was as follows: we used
the randomization of the permutated block to allow an ade-
quate random distribution of patients between the groups.
A function was created in Microsoft Excel (MS Excel), with
randomization between blocks of 6, 8 and 10, and a list was
generated with a sequence of 100 numbers. The randomiza-
tion list was password-protected and was the responsibility
of the study nurse. The sequence of numbers was hidden;
that is, the research nurse had access to the patient’s random
number only after signing the ICF (inclusion in the study)
and inserting the data into the worksheet. The surgeons
participating in the project did not have access to the spread-
sheet. The research nurse utilized email and performed
insertions of information into institutional electronic medical
records to inform the study team of the group in which the
patient was allocated.
The following data were collected from the electronic
medical record: age, body mass index, histological type,
histological grade, tumor size, stage, number of pelvic lymph
nodes, number of paraaortic lymph nodes, total duration of
surgery, and the durations of several procedures, namely,
right pelvic lymphadenectomy, left pelvic lymphadenectomy,
paraaortic lymphadenectomy, hysterectomy and closure of
the vaginal cuff.
In the traditional laparoscopic surgery arm, we used con-
ventional permanent instruments from Karl Storzs (Stuttgart,
Germany), with a high-definition camera and disposable
advanced energy devices LigaSures-Medtronic (Minneapolis,
MN, USA) or Ultracisions (Ethicon Endo-Surgery Inc.,
Cincinnati, OH, USA). All patients had previous clinical and
anesthetic evaluations, radiological evaluations (thoracic and
abdominal computed tomography and magnetic resonance
imaging of the pelvis).
In all but two patients, single docking was used. Robotic
surgery cases were performed with a supraumbilical 13-mm
port for the camera and three 8-mm operating arms disposed
in the arch. Another 12-mm, and sometimes another 5-mm
port, was placed on the right upper abdominal quadrant for
use of the assistant. At the end of the surgery, all specimens
were retrieved through the vagina. In six patients, the
specimens were removed via a Pfannenstiel incision because
of an enlarged uterus. Traditional laparoscopic surgeries
were performed with two 5-mm ports close to the anterior
iliac spine bilaterally and two 12-mm ports located at the
umbilicus and suprapubic region. In all patients, the surgical
plan was to remove the uterus, ovaries, uterine tubes, and
pelvic and paraaortic lymph nodes. The upper anatomical
limit of the dissection of the paraaortic lymph nodes was the
level of the left renal vein.
The medians were compared with the Kruskal-Wallis test.
The categorical variables were compared with the chi-square
test. Statistical analyses were performed using MedCalc for
Windows (version 17.9.2; MedCalc Software, Mariakerke,
Belgium), and p-values less than 0.05 were considered
significant.
The da Vincis robot was donated to our hospital by the
Brazilian government’s Ministry of Science and Technology
to carry out a multidisciplinary project. The aim was to eval-
uate the advantages and disadvantages of robotic surgery in
a public hospital for the treatment of cancer in various spe-
cialties such as urological, digestive, head and neck, thoracic
and gynecological surgeries.
The total cost to the hospital did not include the cost of
the robot itself but did include the costs of hospital admis-
sion, theaters, drugs and pharmacy, blood products, high-
dependence care, imaging, pathology, medical staffing and
rehabilitation therapy. Cost data were analyzed without
considering the cost of the robot acquisition.
In this study, we analyzed the perioperative outcomes
and costs of the patients with endometrial cancer treated by
robotic surgery versus traditional laparoscopic surgery.
’ RESULTS
Eighty-nine patients were randomized. Two candidates in
the robotic arm were excluded (one patient refused surgical
treatment for religious reasons, and the other patient
abandoned treatment). In the traditional laparoscopic arm,
two patients were excluded (one because she had developed
inoperable peritoneal carcinomatosis and another due to
poor clinical condition related to morbid obesity (BMI =
58.6 kg/m2)).
The patients who were distributed between the two arms
of the study were similar according to age, BMI, preoperative
histology, tumor grade, tumor size, and FIGO stage (Table 1).
The median total number of lymph nodes retrieved was
19 (3-61) in the robotic surgery arm and 20 (4-34) in the
traditional laparoscopic arm. The median numbers of retrie-
ved paraaortic lymph nodes were 11.5 (0-32) and 15 (0-41) in
robotic and traditional laparoscopic arms, respectively.
In our study, robotic surgery was more time consuming
than traditional laparoscopic surgery. The median total
duration of the whole procedure was 319.5 (170-520) minutes
in the robotic surgery arm and 248 (85-465) minutes in the
traditional laparoscopic surgery. We also separately analyzed
the time in minutes devoted to each of the following pro-
cedures: right pelvic lymphadenectomy, 44.5 (26-128) vs.
33 (21-77); left pelvic lymphadenectomy, 43.5 (27-110) vs.
31 (18-59); paraaortic lymphadenectomy, 93 (24-139) vs.
77 (40-115); hysterectomy, 32 (15-62) vs. 23 (8-62); and vaginal
closure, 14 (7-39) vs. 15.5 (9-40). The estimated blood loss was
162 (0-2915) ml and 105.5 (0-1465) ml in the robotic and tradi-
tional laparoscopic surgical arms, respectively.
The median hospital stay was three days and was similar
in both groups. One patient in the traditional laparoscopic
surgery arm remained hospitalized for forty-three days until
death due to septicemia. This patient had an infected and
necrotic grade 3 endometrioid carcinoma. In the robotic group,
a death occurred due to an unnoticed perforation of the
duodenum. This patient developed peritonitis, and autopsy
examination confirmed perforation of the duodenum.
In the robotic surgery arm, there was one conversion to
laparotomy to correct a vena cava lesion, while in the tradi-
tional laparoscopic arm, there were two conversions to laparo-
tomy, one due to advanced disease and another for multiple
peritoneal adhesions.
There were eight occurrences of major complications
in each arm. Major complications included vena cava,
duodenal, obturator nerve, iliac artery and ureter injuries.
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Other major complications included cases of thromboembo-
lism and sepsis. Minor complications occurred in six cases in
the robotic surgery arm and in two cases in the traditional
laparoscopic arm. These complications comprised two
cases of urinary tract infection, two cases of hernia in the
trocar sites, one case of panniculitis, one case of vaginal
cuff dehiscence, one case of bladder injury and one case of
intestinal subocclusion. The most severe of all periopera-
tive complications was vena cava injury. This complication
occurred three times in both the robotic and traditional
laparoscopic arms.
Costs analysis
The following costs were considered: the daily cost of
hospitalization, intensive care unit admission, disposable
material, medication, surgical theaters (per minute), medical
gases (per minute), robot instruments; and therapeutic
diagnostic and support services (Table 2). The cost of reus-
able robot instruments was calculated considering that each
instrument could be used in 10 procedures. The standard
staff for both types of surgery consisted of three surgeons, an
anesthesiologist, a circulating nurse, and a scrub nurse.
Statistical analysis of costs was performed using the
software SPSS version 19 (SPSS, Inc, Chicago, IL, USA).
The total costs were compared between the two surgery
groups. For the comparison between the two groups, the U
Mann-Whitney test was used. The chi-square test was used
for nominal variables. The estimated total costs and sub-
categories (in US dollars) of the surgeries performed by robot
versus laparoscopy are presented in Table 2.
Without considering the acquisition and maintenance costs
of the robot, the estimated median total costs for each
endometrial cancer surgical treatment in our institution was
6,812 US dollars (SD ± 1849) for traditional laparoscopic
surgery and 9,655 US dollars (SD ± 850) for robotic surgery
(po0.001).
’ DISCUSSION
With the advent of minimally invasive methods, surgery
for endometrial cancer has evolved substantially in recent
decades (3). One of the major advancements was the change
from open surgery to laparoscopic surgery that occurred
in the late 1990s and that resulted in lower perioperative
Table 1 - Patient characteristics according to surgery type.
Type of surgery (no.) Robotic (42) Traditional laparoscopic (43) p
Age at surgery (average) 60 (47-69) 60 (48-69) 0.36
BMI category 31.7 (21.4-54.2) 30.3 (24.8-42.7) 0.43
Preoperative histology Endometrioid (37) Endometrioid (37) 0.77
Non-endometrioid (5) Non-endometrioid (6)
Grade Low (32) Low (29) 0.20
High (8) High (14)
Size (cm-average) 4.0 (1.5-10.0) 4.0 (0.0-9.0) 0.41
FIGO stage IA (17) IA (18) 0.44
IB (13) IB (16)
II (4) II (1)
IIIA (2) IIIA (1)
IIIC1 (2) IIIC2 (5)
IIIC2 (2) IVB (2)
IVB (2)
Total number of lymph nodes 29.5 (10-93) 34 (5-70) 0.36
Paraaortic lymph nodes 11.5 (0-32) 15 (0-41) 0.08
Pelvic lymph nodes 19 (3-61) 20 (4-34) 0.72
Total length of surgery (minutes) 319.5 (170-520) 248 (164-465) 0.000042
Length (minutes)
Right pelvic 44.5 (26-128) 33 (21-77)
Left pelvic 43.5 (27-110) 31 (18-59)
Paraaortic 93 (24-139) 77 (40-115)
Hysterectomy 32 (15-62) 23 (8-62)
Vaginal closure 14 (7-39) 15.5 (9-40)
Estimated blood loss (ml) 162 (0-2915) 105.5 (0-1465) 0.64
Hospital stay (days) 3 (2-5) 3 (2-43) 0.78
Perioperative death 1 1
Total major complications 8 8 0.96
Vena cava injury 3 3
Duodenal injury 1 0
Obturator nerve injury 1 2
Iliac artery injury 1 0
Ureter injury 1 1
Thromboembolism 1 1
Sepsis 0 1
Total minor complications 6 2 0.97
Urinary tract infection 2 0
Trocar site hernia 1 1
Panniculitis 1 0
Vaginal cuff dehiscence 1 0
Bladder injury 0 1
Intestinal subocclusion 1 0
Conversion to laparotomy 1 2 0.31
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morbidity without losing the radicality or effectiveness of
oncological surgery (4-6).
However, the high complexity of traditional laparoscopic
procedures requires time-consuming training. Different stud-
ies have shown that robotic hysterectomy with lymphade-
nectomy has a shorter learning curve than the laparoscopic
approach (7) and that robotic surgery can be a suitable alter-
native to compensate for the lengthy training time needed to
qualify the gynecological oncology surgeon for laparoscopic
surgery.
In our current study, there were no significant differences
between the patients subjected to robotic and traditional
laparoscopic surgery in relation to age, body mass index,
histological type, histological grade, tumor size, tumor stage
or the total number of lymph nodes retrieved. Obesity poses
a major challenge in laparoscopic surgery for endometrial
carcinoma, and each additional unit of body mass index
increases the risk of failure in complete laparoscopic surgery
by 11% (8). Two-thirds of our patients had a body mass index
greater than thirty. In the population served at our insti-
tution, endometrial carcinoma presents in more advanced
stages (2). Only 14% of our patients had a tumor smaller
than 2 cm.
The median total surgical time was higher in the robotic
surgery group, at 319.5 (170-520) minutes, than in the tradi-
tional laparoscopic surgery group, at 248 (164-465) minutes.
Leitao et al. (9) reported that robotic surgery requires the
same amount of time as laparoscopic surgery until comple-
tion of the learning curve, which is considered to occur with
forty cases.
Regarding the number of lymph nodes removed, Chan
et al. (10) reported that in high-risk and intermediate-risk
endometrial cancer patients, 5-year survival was progres-
sively higher according to the number of lymph nodes
removed (75.3%, 81.5%, 84.1%, 85.3%, and 86.8% survival
for 1, 2-5, 6-10, 11-20, and 420 lymph nodes, respectively).
In another study, Cragun et al. (11) found that patients
with undifferentiated tumors with 11 pelvic lymph nodes
removed had a better overall survival rate than patients with
less than 11 pelvic lymph nodes removed. In our study,
the number of lymph nodes retrieved was equivalent in
both types of surgery, namely, 29.5 (10-93) in robotic surgery
and 34 (5-70) in traditional laparoscopic surgery, which was
considered sufficient.
The number of serious complications was expected to be
higher at the beginning of the learning curve. We observed
the same major complication rates when robotic surgery was
compared with traditional laparoscopic surgery. However,
when we compared the results of the first and second half of
the study, we observed a marked decline in major complica-
tions (11 vs. 5), as well as minor complications (6 vs. 2), in the
second half of the study. For the laparoscopic surgeries, our
two surgeons had already completed the learning curve,
while for robotic surgery, they were just beginning the learn-
ing curve. We did not evaluate the outcomes of robotic surgery
performed by surgeons who were not experienced in endo-
scopic surgery.
We regarded any vena cava injury as a serious complica-
tion regardless of the extent and consequences for the
patient. Vena cava injuries occurred three times in each type
of surgery. In all but one case, the lesion was repaired with-
out conversion to laparotomy. Injury to the vena cava at the
time of the paraaortic lymphadenectomy is an event that has
been reported in different series since the beginning of theTa
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era of minimally invasive surgery (12-14). One patient had
unperceived duodenum perforation. In the immediate post-
operative period, this patient developed peritonitis and sep-
tic shock and subsequently died.
Sectioning of the obturator nerve at the time of pelvic
lymphadenectomy is a complication that has been reported
in some series (15,16). We observed sectioning of the obtu-
rator nerve in one robotic surgery and in two traditional
laparoscopic surgeries. These injuries were successfully repaired
without conversion to laparotomy. Other complications
included two cases of ureter perforation, one case of iliac
artery perforation and two cases of thromboembolism.
The major obstacle to the use of robotic surgery in the
treatment of endometrial cancer is the cost of the system.
The decision to implement robotic surgery in a public
healthcare system should consider the total cost to the
institution, which includes the costs of the robot, hospital
admission, theaters, drugs and pharmacy, blood products,
high-dependence care, imaging, pathology, medical staff and
rehabilitation therapy.
The total cost of robotic surgery depends on multiple
factors that vary between different countries: the type of
hospital, namely, general hospitals versus referral centers;
the volume of surgeries performed; the previous experience
of the team in minimally invasive surgeries; the cost of
disposable materials; the cost of the use of the different
surgical instruments; the duration of operating room use; the
use of medical gases and medicines; and the cost of the team
of medical professionals and paramedics involved. Costs
associated with patient rehabilitation and treatment of com-
plications may also be included. For these reasons, the econo-
mic feasibility studies of robotic surgery present different
results and need to be considered within the reality of each
institution. There are several publications with economic
evaluations of the implementation of robotic hysterectomy
compared to the implementation of laparoscopic or open
surgery. Many of these results should not be generalized
because they compare different cost categories. The costs of
robotic surgery compared to laparoscopic or open surgery
vary greatly in different studies. A comparison of the esti-
mated cost of robotic hysterectomy (in US dollar) in different
countries are presented in table 3 (17-22).
Approximately seven hundred cancer surgeries are per-
formed every month in our institution, and there is only one
robot to be shared between different specialties. The robot
was provided by the government. Since 2009, the surgical
treatment of choice for endometrial carcinoma in our hospital
has been traditional laparoscopic surgery. The use of the
robot was not an option for surgeons in general. The robot
was only available for cases included in research protocols
involving all surgical specialties and for protocols that
had evaluations of the impact of robotic surgery on patient
outcomes and economic viability in the institution as their
research objectives. An analysis of the costs of each proce-
dure will be carried out in the future, along with an analysis
of all specialties.
The costs of the robot-specific supplies are the main driv-
ers of additional costs compared with traditional laparo-
scopic surgery. In our study, robotic hysterectomy for the
treatment of endometrial cancer was 41.7% more expensive
than traditional laparoscopic surgery and had an equivalent
perioperative outcome.
Despite the variations in the absolute values of costs in
different countries, we can clearly state that robotic surgery is
still more expensive than traditional laparoscopic surgery,
and the justification for its introduction into an institution is
still based on reasons other than costs.
One of the most relevant indirect advantages of robotic
surgery is its ability to allow institutions with a low volume
of minimally invasive surgeries to change this profile by
introducing robotic surgery that requires less time to com-
plete the learning curve. Lau et al. (23) have reported that the
rate of minimally invasive surgeries rose from 17% to 98%
with the introduction of robotic surgery. In our institution,
most surgeries for endometrial carcinoma (62%) are per-
formed by laparoscopy (2), and the incorporation of the
robot did not have a great impact on the number of patients
treated by minimally invasive surgery. We have only one
robot that is shared by surgeons of all other specialties in
addition to gynecological oncology. This fact represents a
limitation for the use of the robot for a small number of
patients.
The introduction of robotic surgery in our public hospital
for the treatment of endometrial cancer demonstrated peri-
operative morbidity that was equivalent to that of the tradi-
tional laparoscopic surgery performed by the same surgeons.
The duration of robotic surgery was higher than that of
traditional laparoscopic surgery. The total cost of robotic
surgery was 41% higher than that of traditional laparoscopic
surgery at our institution. Incorporation of the robot did not
have a great impact on the number of patients treated by
minimally invasive surgery because we have only one robot
that is available to a small number of patients.
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